ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 625736 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 625736; 2) Community: the network communities that were significantly associated with the response to NSC 625736; 3) Molecule: the relationships between components within communities and NSC 625736; 4) MDR: the compounds that were significantly associated with the NSC 625736.

NSC Compound Enrichment Correlation
NSC 728035 1N-{2-[7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[ e]pyrrolo[1,2-a][1,4]diazepin-8-yloxy]ethyl}-2-[8-benzyloxy- 7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrro lo[1,2-a][1,4]di 0.0342636096654271 -0.18831697
NSC 740 Methotrexate 0.0342636096654271 0.013110266
NSC 748715 Null 0.0342636096654271 -0.16131178
NSC 149967 Null 0.0342636096654276 -0.27973751
NSC 241494 Null 0.0342636096654276 -0.18958457
NSC 255104 Des-O-methylgeldanamycin 0.0342636096654276 -0.328282
NSC 29443 Null 0.0342636096654276 -0.13887098
NSC 306911 .beta.-D-Glucopyranose, 2,3-O-(diethylstannylene)- 0.0342636096654276 -0.30981966
NSC 35489 Null 0.0342636096654276 -0.050184883
NSC 59984 Null 0.0342636096654276 -0.22552244
Total:44  Current:31    [First] [Prev] [Next] [Last]